EPA Registers MicroGuard Antimicrobial Alloys for Sale With Public Health Claims

Article

Based on the results of extensive efficacy testing, the Environmental Protection Agency (EPA) has registered MicroGuard antimicrobial alloys for sale with public health claims. The registration acknowledges that products made of MicroGuard metals can kill harmful bacteria* responsible for causing millions of infections each year.  When used as directed, MicroGuard touch surfaces are designed to kill greater than 99.9 percent of disease causing bacteria* including methicillin-resistant Staphylococcus aureus (MRSA), a superbug responsible for over 94,000 hospital-acquired infections each year.

Products made of MicroGuard antibacterial materials are the first registered products available for immediate sale.  MicroGuard materials and component hardware are approved for touch surfaces in hospitals, schools, commercial buildings, and homes. Some of the EPA approved applications include: hand and stair railing, door hardware, hospital bedrails, medical IV stands, medical carts and countertops

Designed to replace stainless steel with the added benefit of killing infectious bacteria*, MicroGuard alloys are both fingerprint and stain resistant. PMX Industries will be releasing additional products made of MicroGuard materials as market needs are identified.

“While MicroGuard surfaces are not a substitute for good cleaning and disinfection practices, MicroGuard may be an ideal supplement to a multi-faceted approach to reduce hospital-acquired infections,”  said Tom Bobish, vice president of sales and marketing at PMX. “Unlike antimicrobial coatings which cannot claim to kill infectious bacteria, the antimicrobial properties of MicroGuard will not wear away or be rubbed off. The antibacterial efficacy of MicroGuard remains effective for the life of the product.”

*Staphylococcus aureus, Enterobacter aerogenes, Methicillin-Resistant Staphylococcus aureus  (MRSA), Escherichia coli 0157:H7 and Pseudomonas aeruginosa.

 

 

 

 

 

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content